Tactile Systems Technology IncTCMD
Price$21.71Intrinsic value$41.4291% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $41.42median of 6 methods · middle span $20-$183based on filings through 30 Jun 2026
Market Price $21.71Price as of 1 Oct 2026
Margin of Safety +90.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 22.7% (near-term consensus, capped) · years 2–5: 42.0%/yr (balance of the path).37.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 635.6%Yr 729.2%Yr 822.7%Yr 916.3%Yr 109.9%
42.0% → 9.9%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.2%Yr 128.5%Yr 137.9%Yr 147.2%Yr 156.5%Yr 165.8%Yr 175.1%Yr 184.4%Yr 193.7%Yr 203.0%
9.9% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)9.9%
Discount rate (cost of equity) 8.9%
Volatility vs market (adjusted beta)0.89

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTactile Systems Technology IncTCMDHealth Care
Valuation
P/E20.3×
P/S1.4×
P/B2.3×
EV / Revenue1.2×
EV / EBITDA12.5×
Profitability
Gross margin76.5%
Operating margin-2.0%
Net margin7.1%
FCF margin7.7%
Returns
ROE11.1%
ROA8.9%
ROIC16.1%
Growth
Revenue growth (YoY)19.6%
5-yr fwd EPS growth37.9%
Financial strength
Debt / Equity0.00×
Current ratio4.12×
Altman Z-Score8.0
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.